Tuesday 18 December 2018
Home      All news      Contact us     
Reuters - 1 month ago

Novartis launches third-to-market Remicade copy in Germany

Novartis launched a copy of Johnson Johnson s (J J) inflammation-fighting Remicade in Germany on Thursday as the Swiss drugmaker aims to catch rival biosimilars that are already available in Europe s largest healthcare market.

Related news

Latest News
Hashtags:   

Novartis

 | 

launches

 | 

third

 | 

market

 | 

Remicade

 | 

Germany

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources